Association between glycosylated hemoglobin and newly diagnosed hypertension in a non-diabetic kosovar population: a cross-sectional analysis

Авторы

DOI:

https://doi.org/10.26641/2307-0404.2024.2.307579

Ключевые слова:

vitamin D, glucose, smoking, hypertension

Аннотация

Diabetes mellitus is a common disease followed by cardiovascular complications, it is a metabolic syndrome with multiple etiology that is characterized by chronic hyperglycemia. Hypertension is a serious health condition that is significantly associated with the risks of heart, brain, kidney, and other diseases. Glycosylated hemoglobin (HbA1c) is diagnostic means of diabetes when fasting (venous) glycemia figures are 126 mg/dl (7.0 mmol/l). The purpose of this study is to focus on the diagnosis, and the treatment of the population with diabetes, identifying the necessary targets to guarantee clinical efficacy. Managing diabetes is challenging, and smoking can complicate it. People with diabetes who smoke often need larger doses of insulin to keep their blood sugar near normal levels. To assess the amount of vitamin D bound to hemoglobin, the study analyzed a number of laboratory parameters in patients with type 2 diabetes. The importance of this study is the estimation of the amount of enzyme-linked immunosorbent vitamin D. Laboratory parameters of diabetic patients were divided into three categories based on increased levels of glycosylated hemoglobin. Vitamin D levels were analyzed in these categories with increased HbA1c values. The influence of smoking and hypertension on laboratory parameters of diabetic patients was analyzed. The observations were carried out in the form of a database, and the methods that allowed the results for all parameters were followed. The data on the homogeneity of the selected information groups cover 150 patients diagnosed with diabetes mellitus, 40.67% were men, 59.33% were women. Similarly, (in fasting patients), a high OGTT-2-hour glucose level, the hemoglobin test indicates [A1C(HbA1c)] level, cardiovascular disease, and serum vitamin D. Overall, 47.33% of the patients were deficient in vitamin D. Decreased levels of vitamin D were associated with increased levels of glycosylated hemoglobin, while 22% were deficient. As a result, 74.67% of tobacco users had hypertension. Vitamin D deficiency may increase in patients with diabetes, with increased levels of glycosylated hemoglobin.

Библиографические ссылки

Pertseva NO, Moshenets KI. Definition of the dependence of QTc interval prolongation on glycemic control in patients with type 2 diabetes mellitus. Medicni perspektivi. 2022;27(1):58-64. doi: https://doi.org/10.26641/2307-0404.2022.1.254326

Zinych O, Shuprovych A, Trofymenko O, Komisarenko K. The role of epigenetic modifications in the formation of heterogeneous phenotypes in diabetes mel-litus (a literature review). Medicni perspektivi. 2023;28(3):19-27. doi: https://doi.org/10.26641/2307-0404.2023.3.288928

Koval S, Snihurska I. Role of gut microbiota in the pathogenesis of type 2 diabetes mellitus (literature review). Medicni perspektivi. 2021;26(4):22-30. doi: https://doi.org/10.26641/2307-0404.2021.4.248064

Nikolaychuk M, Shostakovych-Koretskaya L, Budayeva I, Biletska S. Influence of seasonality on vitamin D level in patients with HCV infection and healthy people. Medicni perspektivi. 2021;26(1):184-90. doi: https://doi.org/10.26641/2307-0404.2021.1.228000

Pertseva NO, Gurzhiy OV, Moshenets KI. Depen-dence of heart rate variability on indicators of type 1 diabetes mellitus control. Medicni perspektivi. 2020;25(1):88-95. doi: https://doi.org/10.26641/2307-0404.2020.1.200406

Bartlomiej O, Maciej S, Przybylkowski A. The drug safety information in domestic medical literature. Current Issues in Pharmacy and Medical Sciences. 2022;35(3):111-5. doi: https://doi.org/10.2478/cipms-2022-0021

Ilkov O, Manko N, Bilous S, Didikin G, Klyu-chivska O, Dilay N, et al. Antibacterial and cytotoxic acti-vity of metronidazole and levofloxacin composites with silver nanoparticle. Current Issues in Pharmacy and Medical Sciences. 2021;34(4):224-8. doi: https://doi.org/10.2478/cipms-2021-0040

Malecha-Jedraszek A, Burska A, Matyjaszek-Matuszek B, Donica H. Serum leptin concentration in patients with type 2 diabetes. Current Issues in Pharmacy and Medical Sciences. 2015;28(4):236-40. doi: https://doi.org/10.1515/cipms-2015-0078

Omar SM, Musa IR, Abdelbagi O, Sharif ME, Adam I. The association between glycosylated hemoglobin and newly diagnosed hypertension in a non-diabetic Sudanese population: a cross-sectional study. BMC Cardiovasc Disord. 2022 May 10;22(1):208. doi: https://doi.org/10.1186/s12872-022-02649-y

Malviya V. Investigation of in-vitro antidiabetic study, antioxidant activity and anthelminthic property of various extracts of bitter cumin seeds: Antidiabetic Study, Antioxidant Activity, and Anthelminthic Property of Bitter Cumin Seeds. Scopus Indexed [Internet]. 2023 Jul 31 [cited 2024 Feb 10];16(4):6855-74. doi: https://doi.org/10.37285/ijpsn.2023.16.4.3

Nuamchit T, Siriwittayawan D, Thitiwuthikiat P. The relationship between glycemic control and concomitant hypertension on arterial stiffness in Type II Diabetes. Vasc Health Risk Manag. 2020;16:343. doi: https://doi.org/10.2147/VHRM.S265157

Kassa A, Woldesemayat EM. Hypertension and diabetes mellitus among patients at Hawassa University Comprehensive Specialized Hospital, Hawassa, Southern Ethiopia. Int J Chronic Dis. 2019;2019:1-8. doi: https://doi.org/10.1155/2019/2509242

Au Yeung SL, Luo S, Schooling CM. The impact of glycated hemoglobin on risk of hypertension: a Mendelian randomization study using UK Biobank. J Hypertens. 2020;38:38-44. doi: https://doi.org/10.1097/HJH.0000000000002210

Song J, Wei N, Zhao Y, et al. Elevated glyco-sylated hemoglobin levels and their interactive effects on hypertension risk in nondiabetic Chinese population: a cross-sectional survey. BMC Cardiovasc Disord. 2020;20(1):218. doi: https://doi.org/10.1186/s12872-020-01501-5

de Farias CB, Coelli S, Satler F, et al. Glycated hemoglobin and blood pressure levels in adults with type 2 diabetes: How many patients are on target? Can J Diabetes. 2021;45:334-40. doi: https://doi.org/10.1016/j.jcjd.2020.10.002

Huang X, Qin C, Guo X, Cao F, Tang C. Association of hemoglobin A1c with the incidence of hyper-tension: A large prospective study. Front Endocrinol (Lausanne). 2023 Jan 16;13:1098012. doi: https://doi.org/10.3389/fendo.2022.1098012

Lou Y, Zhang Y, Zhao P, Qin P, et al. Association of fasting plasma glucose change trajectory and risk of hypertension: A cohort study in China. Endocr Connect. 2022;11(1):210464. doi: https://doi.org/10.1530/EC-21-0464

Liu L, Zhen D, Fu S, Sun W, Li H, Zhao N, et al. Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: A 3-year cohort study. Diabetol Metab Syndr. 2022;14(1):54. doi: https://doi.org/10.1186/s13098-022-00827-8

Загрузки

Опубликован

2024-06-28

Как цитировать

1.
Dreshaj A, Dreshaj A, Veseli D, Sinanaj D, Bresa A, Morina E, Dehari S. Association between glycosylated hemoglobin and newly diagnosed hypertension in a non-diabetic kosovar population: a cross-sectional analysis. Med. perspekt. [Интернет]. 28 июнь 2024 г. [цитируется по 17 июль 2024 г.];29(2):79-87. доступно на: https://journals.uran.ua/index.php/2307-0404/article/view/307579

Выпуск

Раздел

CLINICAL MEDICINE